Patents Assigned to FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD.
  • Crystal form of tri-cycle compound and application thereof
    Patent number: 11952388
    Abstract: Disclosed are crystal form A and crystal form B of a compound represented by formula (I), and application thereof in the preparation of medicaments for treating HBV-related diseases.
    Type: Grant
    Filed: August 23, 2019
    Date of Patent: April 9, 2024
    Assignee: Fujian Akeylink Biotechnology Co., Ltd.
    Inventors: Jing Wang, Zhigan Jiang, Haiying He, Yaxun Yang
  • Crystal form as ASK1 inhibitor and preparation method and application thereof
    Patent number: 11814382
    Abstract: Provided are crystal forms A, B, C and D of a compound of formula (I), and application of the crystal forms in the preparation of drugs for treating ASK1-related diseases.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: November 14, 2023
    Assignee: FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD.
    Inventors: Shengbin Zhang, Ning Li, Tao Yu, Yusheng Fu, Jiahu Wu, Chengde Wu
  • Crystal form of hepatitis B surface antigen inhibitor and application thereof
    Patent number: 11807647
    Abstract: Disclosed is a crystal form of a hepatitis B surface antigen inhibitor and a preparation method, and an application of the crystal form in the preparation of the hepatitis B surface antigen inhibitor.
    Type: Grant
    Filed: September 18, 2020
    Date of Patent: November 7, 2023
    Assignee: FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD.
    Inventors: Zhe Cai, Fei Sun, Charles Z. Ding
  • Crystal form of c-MET inhibitor and salt form thereof and preparation method therefor
    Patent number: 11465986
    Abstract: Disclosed are a crystal form of a c-MET inhibitor and a salt form thereof and a preparation method therefor. Specifically involved are the compound as shown in formula (I), and a salt form and a crystal form thereof, and also included is the use of the crystal form and the salt form in the preparation of medicines for treating cancers.
    Type: Grant
    Filed: April 26, 2019
    Date of Patent: October 11, 2022
    Assignee: FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD.
    Inventors: Xiongbin Xu, Gang Li, Ting Yao, Kun Wang, Lihong Hu, Charles Z. Ding